Predictors of survival in patients with bone metastasis of lung cancer

Clinical Orthopaedics and Related Research
Hideshi SugiuraTetsuya Mitsudomi

Abstract

The prognosis of patients with bone metastasis from lung cancer has not been well documented. We assessed the survival rates after bone metastasis and prognostic factors in 118 patients with bone metastases from lung cancer. The cumulative survival rates after bone metastasis from lung cancer were 59.9% at 6 months, 31.6% at 1 year, and 11.3% at 2 years. The mean survival was 9.7 months (median, 7.2 months; range, 0.1-74.5 months). A favorable prognosis was more likely in women and patients with adenocarcinoma, solitary bone metastasis, no metastases to the appendicular bone, no pathologic fractures, performance status 1 or less, use of systemic chemotherapy, and use of an epithelial growth factor receptor inhibitor. Analyses of single and multiple variables indicated better prognoses for patients with adenocarcinoma, no evidence of appendicular bone metastases, and treatment with an epithelial growth factor receptor inhibitor. The mean survival period was longer in a small group treated with an epithelial growth factor receptor inhibitor than in the larger untreated group. The data preliminarily suggest treatment with an epithelial growth factor receptor inhibitor may improve survival after bone metastasis.

References

Dec 1, 1982·American Journal of Clinical Oncology·M M OkenP P Carbone
Oct 1, 1994·International Orthopaedics·K TomitaY Toribatake
Apr 6, 1999·Japanese Journal of Cancer Research : Gann·M AndoY Hasegawa
Feb 27, 2001·Spine·K TomitaT Akamaru
Sep 14, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Roy S HerbstPatricia Mucci LoRusso
Jan 18, 2003·Lancet·Akira InoueToshihiro Nukiwa
Dec 14, 2004·Cancer·Yvette M van der LindenUNKNOWN Dutch Bone Metastasis Study Group
Mar 2, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Tetsuya MitsudomiYasushi Yatabe
Apr 28, 2005·The Journal of Bone and Joint Surgery. British Volume·H KatagiriK Nakanishi

❮ Previous
Next ❯

Citations

Jun 21, 2011·Clinical & Experimental Metastasis·Koh FurugakiKazushige Mori
Jul 16, 2013·Pathology Oncology Research : POR·Paweł KrawczykJanusz Milanowski
Oct 8, 2009·Journal of Palliative Medicine·Federico Ampil, Roxana Baluna
Jan 1, 2011·BMJ Case Reports·Feng Xiao HuangHelong Zhang
Jan 29, 2014·Laboratory Investigation; a Journal of Technical Methods and Pathology·Jaclyn Y HungSherry L Abboud-Werner
Apr 27, 2012·Case Reports in Medicine·Majid Sajjadi SaraviFariborz Eshghi
Jun 11, 2014·BMC Cancer·Mélanie DeberneFrançois Goldwasser
Mar 17, 2016·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Hisaki AibaTakanobu Otsuka
Jul 2, 2015·American Journal of Respiratory and Critical Care Medicine·Silvestre VicentFernando Lecanda
Jun 25, 2016·Journal of Surgical Case Reports·Ryan C TurnerBill D Underwood
Oct 30, 2014·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·J Fang, Q Xu
Jul 4, 2017·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Yang ZhouZhi-Li Liu
Jan 25, 2018·American Journal of Respiratory and Critical Care Medicine·Jesse Roman
May 3, 2014·Therapeutic Advances in Medical Oncology·Chiara D'AntonioFilippo de Marinis
May 6, 2019·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Sho DohzonoHiroaki Nakamura
Nov 6, 2018·The Journal of the American Academy of Orthopaedic Surgeons·Christopher N JohnsonMatthew J Thompson
Jun 3, 2009·The Journal of Bone and Joint Surgery. American Volume·Jacob BickelsZvi Lidar
Jun 3, 2009·The Journal of Bone and Joint Surgery. American Volume·Valerae O Lewis
Sep 21, 2013·Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]·H RiefJ Debus
Dec 17, 2011·International Journal of Clinical Oncology·Manabu HoshiHiroaki Nakamura
Jul 22, 2014·Cancer Medicine·Hirohisa KatagiriHirofumi Ogawa
Sep 25, 2019·The Journal of International Medical Research·Leyi CaiHua Chen
May 20, 2020·The Journal of International Medical Research·Xiao-Tian WuTing Ge
Sep 15, 2011·Archives of Orthopaedic and Trauma Surgery·Xiaodong TangTao Ji
Jul 8, 2020·Archives of Craniofacial Surgery·Jonghyun ParkTae Hui Bae

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2021 Meta ULC. All rights reserved